BIG
EBS icon

Bellwether Investment Group’s Emergent Biosolutions EBS Stock Holding History

Bellwether Investment Group’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$33K Buy
+1,175
New +$46.1K 0.04% 291

Other funds holding EBS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bellwether Investment Group's EBS Position: Q2 2016 in Review

Bellwether Investment Group opened a new position in Emergent Biosolutions (EBS) in Q2 2016: 1,175 shares worth $33K. The stake represents 0.04% of the portfolio and ranks #291 among its holdings.

224 funds tracked by Wall St. Rank hold EBS as of Q2 2016.

  • Bellwether Investment Group held 1,175 shares of Emergent Biosolutions worth $33K as of Q2 2016.
  • Emergent Biosolutions was a new Bellwether Investment Group position in Q2 2016.
  • Emergent Biosolutions made up 0.04% of Bellwether Investment Group's portfolio in Q2 2016, its #291 holding.
  • 224 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2016.

Based on Bellwether Investment Group's 13F filing for Q2 2016, filed 18 Aug 2016.